Evan Morgan
Overview
Explore the profile of Evan Morgan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
125
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morgan E, Schnell P, Singh P, Fareed N
Digit Health
. 2022 Jul;
8:20552076221109553.
PMID: 35837662
Background: Outpatient portal technology can improve patient engagement. For pregnant individuals, the level of engagement could have important implications for maternal and infant outcomes. Objective: This study: (1) cross-sectionally and...
2.
Singh P, Jonnalagadda P, Morgan E, Fareed N
J Am Med Inform Assoc
. 2021 Nov;
29(2):364-371.
PMID: 34741505
To report the relationship of outpatient portal (OPP) use with clinical risk, area social determinants of health (SDoH), and race/ethnicity among pregnant women. Regression models predicting overall and individual portal...
3.
Rinehardt H, Kassem M, Morgan E, Palettas M, Stephens J, Suresh A, et al.
Eur J Breast Health
. 2021 Oct;
17(4):371-377.
PMID: 34651117
Objective: Leptomeningeal carcinomatosis (LMC), a common complication of advanced malignancies, is associated with high morbidity and mortality, yet diagnosis and treatment decisions remain challenging. This study describes the diagnostic and...
4.
Sardesai S, Sukumar J, Kassem M, Palettas M, Stephens J, Morgan E, et al.
Cardiooncology
. 2020 Dec;
6(1):26.
PMID: 33292843
Background: Trastuzumab-induced cardiotoxicity (TIC) can lead to early discontinuation of adjuvant therapy, however there is limited evidence on long-term survival outcomes in patients with operable human epidermal growth factor receptor...
5.
Liu J, Suresh A, Palettas M, Stephens J, Ganju A, Morgan E, et al.
Eur J Breast Health
. 2020 Jul;
16(3):201-207.
PMID: 32656521
Objective: The primary objective of this study was to delineate differences in management, overall and distant disease-free survival in males diagnosed with breast cancer and treated at The Ohio State...
6.
Vazquez D, Rosenberg S, Gelber S, Ruddy K, Morgan E, Recklitis C, et al.
Psychooncology
. 2020 Jun;
29(8):1312-1320.
PMID: 32515073
Objective: Young breast cancer patients experience greater psychosocial distress compared with older patients, which raises concern for their risk of posttraumatic stress disorder (PTSD). We sought to characterize the prevalence...
7.
Boutrid H, Kassem M, Tozbikian G, Morgan E, White J, Shah M, et al.
Front Endocrinol (Lausanne)
. 2020 May;
11:228.
PMID: 32411090
Primary small cell carcinoma of the breast (SCCB) is a rare tumor subtype comprising <0.1% of all breast carcinomas. Here we present a case of thyroid transcription factor-1 (TTF-1) positive...
8.
Mousa L, Stephens J, Berger M, Ramaswamy B, Lustberg M, Sardesai S, et al.
Support Care Cancer
. 2020 Mar;
28(11):5537-5545.
PMID: 32185556
Purpose: The goal of chemotherapy for metastatic breast cancer (MBC) is palliation of symptoms while minimizing treatment-related toxicities. It remains unclear whether use of granulocyte colony-stimulating factor (G-CSF) to maintain...
9.
Sardesai S, Badawi M, Mrozek E, Morgan E, Phelps M, Stephens J, et al.
Invest New Drugs
. 2020 Jan;
38(5):1400-1410.
PMID: 31953695
Upregulation of Notch pathway is associated with poor prognosis in breast cancer. We present the results of a phase I study of an oral selective gamma secretase (GS) inhibitor (critical...
10.
Suresh A, Ganju A, Morgan E, Palettas M, Stephens J, Liu J, et al.
Invest New Drugs
. 2020 Jan;
38(5):1605-1611.
PMID: 31938949
Purpose Capecitabine is widely used as a single agent on a 21-day cycle in the management of metastatic breast cancer (MBC). Our primary objective was to compare the standard dosing...